Parasites, Hosts and Diseases

Skip to main navigation Skip to main content

OPEN ACCESS

Page Path

HOME
BROWSE ARTICLES

Author index detail contents
Shigeyuki Kano	4 Articles
Primaquine Administration after Falciparum Malaria Treatment in Malaria Hypoendemic Areas with High Incidence of Falciparum and Vivax Mixed Infection: Pros and Cons Polrat Wilairatana, Noppadon Tangpukdee, Shigeyuki Kano, Srivicha Krudsood Korean J Parasitol 2010;48(2):175-177. Published online June 17, 2010 DOI: https://doi.org/10.3347/kjp.2010.48.2.175 Abstract PDF Mixed infections of Plasmodium falciparum and Plasmodium vivax is high (~30%) in some malaria hypoendemic areas where the patients present with P. falciparum malaria diagnosed by microscopy. Conventional treatment of P. falciparum with concurrent chloroquine and 14 days of primaquine for all falciparum malaria patients may be useful in areas where mixed falciparum and vivax infections are high and common and also with mild or moderate G6PD deficiency in the population even with or without subpatent vivax mixed infection. It will be possibly cost-effective to reduce subsequent vivax illness if the patients have mixed vivax infection. Further study to prove this hypothesis may be warranted. Citations Citations to this article as recorded by Impact of enhanced malaria control on the competition between Plasmodium falciparum and Plasmodium vivax in India Olivia Prosper, Maia Martcheva Mathematical Biosciences.2013; 242(1): 33. CrossRef Elimination Therapy for the Endemic Malarias J. Kevin Baird Current Infectious Disease Reports.2012; 14(3): 227. CrossRef 7,891 View 76 Download Crossref Gametocyte Clearance in Uncomplicated and Severe Plasmodium falciparum Malaria after Artesunate-Mefloquine Treatment in Thailand Noppadon Tangpukdee, Srivicha Krudsood, Sriripun Srivilairit, Nanthaporn Phophak, Putza Chonsawat, Wimon Yanpanich, Shigeyuki Kano, Polrat Wilairatana Korean J Parasitol 2008;46(2):65-70. Published online June 20, 2008 DOI: https://doi.org/10.3347/kjp.2008.46.2.65 Abstract PDF Artemisinin-based combination therapy (ACT) is currently promoted as a strategy for treating both uncomplicated and severe falciparum malaria, targeting asexual blood-stage Plasmodium falciparum parasites. However, the effect of ACT on sexual-stage parasites remains controversial. To determine the clearance of sexual-stage P. falciparum parasites from 342 uncomplicated, and 217 severe, adult malaria cases, we reviewed and followed peripheral blood sexual-stage parasites for 4 wk after starting ACT. All patients presented with both asexual and sexual stage parasites on admission, and were treated with artesunate-mefloquine as the standard regimen. The results showed that all patients were asymptomatic and negative for asexual forms before discharge from hospital. The percentages of uncomplicated malaria patients positive for gametocytes on days 3, 7, 14, 21, and 28 were 41.5, 13.1, 3.8, 2.0, and 2.0%, while the percentages of gametocyte positive severe malaria patients on days 3, 7, 14, 21, and 28 were 33.6, 8.2, 2.7, 0.9, and 0.9%, respectively. Although all patients were negative for asexual parasites by day 7 after completion of the artesunate-mefloquine course, gametocytemia persisted in some patients. Thus, a gametocytocidal drug, e.g., primaquine, may be useful in combination with an artesunate-mefloquine regimen to clear gametocytes, so blocking transmission more effectively than artesunate alone, in malaria transmission areas. Citations Citations to this article as recorded by Knowledge about Asymptomatic Malaria and Acceptability of Using Artemisia afra Tea among Health Care Workers (HCWs) in Yaoundé, Cameroon: A Cross-Sectional Survey Abenwie Suh Nchang, Lahngong Shinyuy, Sandra Noukimi, Sylvia Njong, Sylvie Bambara, Edgar Kalimba, Joseph Kamga, Stephen Ghogomu, Michel Frederich, Jean Talom, Jacob Souopgui, Annie Robert International Journal of Environmental Research and Public Health.2023; 20(13): 6309. CrossRef Parasite clearance dynamics in children hospitalised with severe malaria in the Ho Teaching Hospital, Volta Region, Ghana Laura Paris, Richmond G. Tackie, Khalid B. Beshir, John Tampuori, Gordon A. Awandare, Fred N. Binka, Britta C. Urban, Bismarck Dinko, Colin J. Sutherland Parasite Epidemiology and Control.2022; 19: e00276. CrossRef NPC1161B, an 8-Aminoquinoline Analog, Is Metabolized in the Mosquito and Inhibits Plasmodium falciparum Oocyst Maturation Timothy Hamerly, Rebecca E. Tweedell, Bernadette Hritzo, Vincent O. Nyasembe, Babu L. Tekwani, N. P. Dhammika Nanayakkara, Larry A. Walker, Rhoel R. Dinglasan Frontiers in Pharmacology.2019;[Epub] CrossRef Recent Advances in Transmission-Blocking Drugs for Malaria Elimination Ishan Wadi, Mahendra Nath, Anupkumar R Anvikar, Pargat Singh, Abhinav Sinha Future Medicinal Chemistry.2019; 11(23): 3047. CrossRef Comprehensive review on various strategies for antimalarial drug discovery Mitali Mishra, Vikash K. Mishra, Varsha Kashaw, Arun K. Iyer, Sushil Kumar Kashaw European Journal of Medicinal Chemistry.2017; 125: 1300. CrossRef Plasmodium falciparum genotype and gametocyte prevalence in children with uncomplicated malaria in coastal Ghana Ruth Ayanful-Torgby, Akua Oppong, Joana Abankwa, Festus Acquah, Kimberly C. Williamson, Linda Eva Amoah Malaria Journal.2016;[Epub] CrossRef The Nonartemisinin Sesquiterpene Lactones Parthenin and Parthenolide Block Plasmodium falciparum Sexual Stage Transmission Jared N. Balaich, Derrick K. Mathias, Baldwyn Torto, Bryan T. Jackson, Dingyin Tao, Babak Ebrahimi, Brian B. Tarimo, Xavier Cheseto, Woodbridge A. Foster, Rhoel R. Dinglasan Antimicrobial Agents and Chemotherapy.2016; 60(4): 2108. CrossRef Sexual development in Plasmodium parasites: knowing when it's time to commit Gabrielle A. Josling, Manuel Llinás Nature Reviews Microbiology.2015; 13(9): 573. CrossRef Gametocyte Clearance Kinetics Determined by Quantitative Magnetic Fractionation in Melanesian Children with Uncomplicated Malaria Treated with Artemisinin Combination Therapy Stephan Karl, Moses Laman, Brioni R. Moore, John Benjamin, Tamarah Koleala, Clemencia Ibam, Bernadine Kasian, Peter M. Siba, Andreea Waltmann, Ivo Mueller, Robert C. Woodward, Timothy G. St. Pierre, Timothy M. E. Davis Antimicrobial Agents and Chemotherapy.2015; 59(8): 4489. CrossRef Strategic use of antimalarial drugs that block falciparum malaria parasite transmission to mosquitoes to achieve local malaria elimination Rashad Abdul-Ghani, John C. Beier Parasitology Research.2014; 113(10): 3535. CrossRef A Male and Female Gametocyte Functional Viability Assay To Identify Biologically Relevant Malaria Transmission-Blocking Drugs A. Ruecker, D. K. Mathias, U. Straschil, T. S. Churcher, R. R. Dinglasan, D. Leroy, R. E. Sinden, M. J. Delves Antimicrobial Agents and Chemotherapy.2014; 58(12): 7292. CrossRef Comparison of three methods for detection of gametocytes in Melanesian children treated for uncomplicated malaria Stephan Karl, Moses Laman, Tamarah Koleala, Clemencia Ibam, Bernadine Kasian, Nola N’Drewei, Anna Rosanas-Urgell, Brioni R Moore, Andreea Waltmann, Cristian Koepfli, Peter M Siba, Inoni Betuela, Robert C Woodward, Timothy G St Pierre, Ivo Mueller, Timothy Malaria Journal.2014;[Epub] CrossRef The Effect of Primaquine on Gametocyte Development and Clearance in the Treatment of Uncomplicated Falciparum Malaria With Dihydroartemisinin-Piperaquine in South Sumatra, Western Indonesia: An Open-Label, Randomized, Controlled Trial Inge Sutanto, Sri Suprijanto, Ayleen Kosasih, Muhamad S. Dahlan, Din Syafruddin, Rita Kusriastuti, William A. Hawley, Neil F. Lobo, Feiko O. ter Kuile Clinical Infectious Diseases.2013; 56(5): 685. CrossRef Fitness components and natural selection: why are there different patterns on the emergence of drug resistance in Plasmodium falciparum and Plasmodium vivax? Kristan A Schneider, Ananias A Escalante Malaria Journal.2013;[Epub] CrossRef Effects of Antimalarial Molecules on the Gametocyte Stage of Plasmodium falciparum: The Debate Odile Dechy-Cabaret, Françoise Benoit-Vical Journal of Medicinal Chemistry.2012; 55(23): 10328. CrossRef Efficacy of different primaquine-based antimalarial regimens against Plasmodium falciparum gametocytemia Eliana M. Arango, Yulieth A. Upegui, Jaime Carmona-Fonseca Acta Tropica.2012; 122(2): 177. CrossRef A high-throughput assay for the identification of malarial transmission-blocking drugs and vaccines Michael J. Delves, Chandra Ramakrishnan, Andrew M. Blagborough, Didier Leroy, Timothy N.C. Wells, Robert E. Sinden International Journal for Parasitology.2012; 42(11): 999. CrossRef Plasmodium Cell Biology Should Inform Strategies Used In The Development Of Antimalarial Transmission-Blocking Drugs Michael J Delves Future Medicinal Chemistry.2012; 4(18): 2251. CrossRef Laboratory Diagnosis of Tropical Infections Bryan H. Schmitt, Jon E. Rosenblatt, Bobbi S. Pritt Infectious Disease Clinics of North America.2012; 26(2): 513. CrossRef Routine delivery of artemisinin-based combination treatment at fixed health facilities reduces malaria prevalence in Tanzania: an observational study Rashid A Khatib, Jacek Skarbinski, Joseph D Njau, Catherine A Goodman, Berty F Elling, Elizeus Kahigwa, Jacquelin M Roberts, John R MacArthur, Julie R Gutman, Abdunoor M Kabanywanyi, Ernest E Smith, Masha F Somi, Thomas Lyimo, Alex Mwita, Blaise Genton, M Malaria Journal.2012;[Epub] CrossRef Primaquina, gametocitemia de Plasmodium falciparum y bloqueo de transmisión: ineficacia del actual régimen de dosificación Jaime Carmona-Fonseca, Eliana María Arango Flórez MedUNAB.2012; 15(1): 14. CrossRef A Sub-Microscopic Gametocyte Reservoir Can Sustain Malaria Transmission Stephan Karl, David Gurarie, Peter A. Zimmerman, Charles H. King, Tim G. St. Pierre, Timothy M. E. Davis, Steffen Borrmann PLoS ONE.2011; 6(6): e20805. CrossRef Appropriate Time for Primaquine Treatment to Reduce Plasmodium falciparum Transmission in Hypoendemic Areas Polrat Wilairatana, Srivicha Krudsood, Noppadon Tangpukdee The Korean Journal of Parasitology.2010; 48(2): 179. CrossRef Artemisinin-based combination therapies and their introduction in Japan Shigeyuki Kano Journal of Infection and Chemotherapy.2010; 16(6): 375. CrossRef Transmission blocking activity of a standardized neem (Azadirachta indica) seed extract on the rodent malaria parasite Plasmodium berghei in its vector Anopheles stephensi Leonardo Lucantoni, Rakiswendé S Yerbanga, Giulio Lupidi, Luciano Pasqualini, Fulvio Esposito, Annette Habluetzel Malaria Journal.2010;[Epub] CrossRef A Lethal Case of Plasmodium falciparum Infection in a Young Patient with End-stage Renal Failure Who Underwent Regular Hemodialysis Anggoro Budi Hartopo, Doni Priambodo Wijisaksono Internal Medicine.2010; 49(17): 1867. CrossRef The impact of human reservoir of malaria at a community-level on individual malaria occurrence in a low malaria transmission setting along the Thai-Myanmar border Saranath Lawpoolsri, Irwin F Chavez, Surapon Yimsamran, Supalap Puangsa-art, Nipon Thanyavanich, Wanchai Maneeboonyang, Wuthichai Chaimungkun, Pratap Singhasivanon, James H Maguire, Laura L Hungerford Malaria Journal.2010;[Epub] CrossRef Modular Synthesis and in Vitro and in Vivo Antimalarial Assessment of C-10 Pyrrole Mannich Base Derivatives of Artemisinin Bénédicte Pacorel, Suet C. Leung, Andrew V. Stachulski, Jill Davies, Livia Vivas, Hollie Lander, Stephen A. Ward, Marcel Kaiser, Reto Brun, Paul M. O’Neill Journal of Medicinal Chemistry.2010; 53(2): 633. CrossRef Optimally timing primaquine treatment to reduce Plasmodium falciparum transmission in low endemicity Thai-Myanmar border populations Saranath Lawpoolsri, Eili Y Klein, Pratap Singhasivanon, Surapon Yimsamran, Nipon Thanyavanich, Wanchai Maneeboonyang, Laura L Hungerford, James H Maguire, David L Smith Malaria Journal.2009;[Epub] CrossRef Effects of mefloquine and artesunate mefloquine on the emergence, clearance and sex ratio of Plasmodium falciparum gametocytes in malarious children Akintunde Sowunmi, Oluchi O Nkogho, Titilope M Okuboyejo, Grace O Gbotosho, Christian T Happi, Elsie O Adewoye Malaria Journal.2009;[Epub] CrossRef 9,653 View 110 Download Crossref Clinical efficacy of chloroquine versus artemether-lumefantrine for Plasmodium vivax treatment in Thailand Srivicha Krudsood, Noppadon Tangpukdee, Sant Muangnoicharoen, Vipa Thanachartwet, Nutthanej Luplertlop, Siripan Srivilairit, Polrat Wilairatana, Shigeyuki Kano, Pascal Ringwald, Sornchai Looareesuwan Korean J Parasitol 2007;45(2):111-114. Published online June 20, 2007 DOI: https://doi.org/10.3347/kjp.2007.45.2.111 Abstract PDF Chloroquine remains the drug of choice for the treatment of vivax malaria in Thailand. Mixed infections of falciparum and vivax malaria are also common in South-East Asia. Laboratory confirmation of malaria species is not generally available. This study aimed to find alternative regimens for treating both malaria species by using falciparum antimalarial drugs. From June 2004 to May 2005, 98 patients with Plasmodium vivax were randomly treated with either artemether-lumefantrine (n = 47) or chloroquine (n = 51). Both treatments were followed by 15 mg of primaquine over 14 days. Adverse events and clinical and parasitological outcomes were recorded and revealed similar in both groups. The cure rate was 97.4% for the artemether-lumefantrine treated group and 100% for the chloroquine treated group. We concluded that the combination of artemether-lumefantrine and primaquine was well tolerated, as effective as chloroquine and primaquine, and can be an alternative regimen for treatment of vivax malaria especially in the event that a mixed infection of falciparum and vivax malaria could not be ruled out. Citations Citations to this article as recorded by Drug resistance markers in Plasmodium vivax isolates from a Kanchanaburi province, Thailand between January to May 2023 Thanawat Sridapan, Paweesuda Rattanakoch, Kaewkanha Kijprasong, Suttipat Srisutham, Kristan Alexander Schneider PLOS ONE.2024; 19(7): e0304337. CrossRef Adapted Guidelines for Malaria Case Management in Sudan Samah Elhassan, Sahar Khalid Mohamed, Khlood Fathi Hassan Alnaeem, Ahmed Abdulgadir Noureddin, Samah Kamaleldeen Bakrri Abass, Fadwa Mohamed Saad, Technical Advisory Committee Sudan Journal of Medical Sciences.2024; 19(4): 531. CrossRef Plasmodium knowlesi as a model system for characterising Plasmodium vivax drug resistance candidate genes Lisa H. Verzier, Rachael Coyle, Shivani Singh, Theo Sanderson, Julian C. Rayner, Paulo Pimenta PLOS Neglected Tropical Diseases.2019; 13(6): e0007470. CrossRef Management of relapsingPlasmodium vivaxmalaria Cindy S Chu, Nicholas J White Expert Review of Anti-infective Therapy.2016; 14(10): 885. CrossRef Evaluation of Efficacy of Chloroquine for Plasmodium Vivax Infection Using Parasite Clearance Times: A 10-Year Study and Systematic Review Hariharan Subramony, Noppadon Tangpukdee, Srivicha Krudsood, Kittiyod Poovorawan, Sant Muangnoicharoen, Polrat Wilairatana Annals of the Academy of Medicine, Singapore.2016; 45(7): 303. CrossRef Efficacy and safety of artemisinin combination therapy (ACT) for non-falciparum malaria: a systematic review Benjamin J Visser, Rosanne W Wieten, Daniëlle Kroon, Ingeborg M Nagel, Sabine Bélard, Michèle van Vugt, Martin P Grobusch Malaria Journal.2014;[Epub] CrossRef Malaria: an update on current chemotherapy Benjamin J Visser, Michèle van Vugt, Martin P Grobusch Expert Opinion on Pharmacotherapy.2014; 15(15): 2219. CrossRef Effectiveness of Artemether/Lumefantrine for the Treatment of Uncomplicated Plasmodium vivax and P. falciparum Malaria in Young Children in Papua New Guinea Nicolas Senn, Patricia Rarau, Doris Manong, Mary Salib, Peter Siba, John C. Reeder, Stephen J. Rogerson, Blaise Genton, Ivo Mueller Clinical Infectious Diseases.2013; 56(10): 1413. CrossRef Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria Nithya Gogtay, Sridharan Kannan, Urmila M Thatte, Piero L Olliaro, David Sinclair Cochrane Database of Systematic Reviews.2013;[Epub] CrossRef Efficacy of artemether-lumefantrine as a treatment for uncomplicated Plasmodium vivax malaria in eastern Sudan Tajeldin M Abdallah, Abdel Aziem A Ali, Mohammed Bakri, Gasim I Gasim, Imad R Musa, Ishag Adam Malaria Journal.2012;[Epub] CrossRef Therapeutic efficacy of artemether-lumefantrine for Plasmodium vivax infections in a prospective study in Guyana Daniel Eibach, Nicolas Ceron, Karanchand Krishnalall, Keith Carter, Guillaume Bonnot, Anne-Lise Bienvenu, Stéphane Picot Malaria Journal.2012;[Epub] CrossRef Coartem®: a decade of patient-centric malaria management Kamal Hamed, Heiner Grueninger Expert Review of Anti-infective Therapy.2012; 10(6): 645. CrossRef Open-label trial with artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria three years after its broad introduction in Jimma Zone, Ethiopia Teferi Eshetu, Nasir Abdo, Kunuz H Bedru, Sintayehu Fekadu, Andreas Wieser, Michael Pritsch, Thomas Löscher, Nicole Berens-Riha Malaria Journal.2012;[Epub] CrossRef Primaquine in vivax malaria: an update and review on management issues Deepika Fernando, Chaturaka Rodrigo, Senaka Rajapakse Malaria Journal.2011;[Epub] CrossRef Plasmodium vivax treatments Ric N. Price, Nicholas M. Douglas, Nicholas M. Anstey, Lorenz von Seidlein Current Opinion in Infectious Diseases.2011; 24(6): 578. CrossRef Pyronaridine-Artesunate versus Chloroquine in Patients with Acute Plasmodium vivax Malaria: A Randomized, Double-Blind, Non-Inferiority Trial Yi Poravuth, Duong Socheat, Ronnatrai Rueangweerayut, Chirapong Uthaisin, Aung Pyae Phyo, Neena Valecha, B. H. Krishnamoorthy Rao, Emiliana Tjitra, Asep Purnama, Isabelle Borghini-Fuhrer, Stephan Duparc, Chang-Sik Shin, Lawrence Fleckenstein, Lorenz von S PLoS ONE.2011; 6(1): e14501. CrossRef The Use of Artemether-Lumefantrine for the Treatment of Uncomplicated Plasmodium vivax Malaria Quique Bassat, David Joseph Diemert PLoS Neglected Tropical Diseases.2011; 5(12): e1325. CrossRef Confirmed Vivax Resistance to Chloroquine and Effectiveness of Artemether-Lumefantrine for the Treatment of Vivax Malaria in Ethiopia Ambachew M. Yohannes, Pascal Ringwald, Awash Teklehaimanot, Yngve Bergqvist The American Journal of Tropical Medicine and Hygiene.2011; 84(1): 137. CrossRef Efficacy and safety of chloroquine for treatment in patients with uncomplicated Plasmodium vivax infections in endemic countries Cho Naing, Kyan Aung, Daw-Khin Win, Mak Joon Wah Transactions of the Royal Society of Tropical Medicine and Hygiene.2010; 104(11): 695. CrossRef Artemisinin combination therapy for vivax malaria Nicholas M Douglas, Nicholas M Anstey, Brian J Angus, Francois Nosten, Ric N Price The Lancet Infectious Diseases.2010; 10(6): 405. CrossRef The 'non-falciparum' malarias: the roles of epidemiology, parasite biology, clinical syndromes, complications and diagnostic rigour in guiding therapeutic strategies J. D. Maguire, J. K. Baird Annals of Tropical Medicine & Parasitology.2010; 104(4): 283. CrossRef Application of mobile-technology for disease and treatment monitoring of malaria in the "Better Border Healthcare Programme" Pongthep Meankaew, Jaranit Kaewkungwal, Amnat Khamsiriwatchara, Podjadeach Khunthong, Pratap Singhasivanon, Wichai Satimai Malaria Journal.2010;[Epub] CrossRef Resistance to Therapies for Infection byPlasmodium vivax J. Kevin Baird Clinical Microbiology Reviews.2009; 22(3): 508. CrossRef 8,606 View 100 Download Crossref Minor liver profile dysfunctions in Plasmodium vivax, P. malariae and P. ovale patients and normalization after treatment Noppadon Tangpukdee, Vipa Thanachartwet, Srivicha Krudsood, Nutthanej Luplertlop, Karnchana Pornpininworakij, Kobsiri Chalermrut, Sasikarn Phokham, Shigeyuki Kano, Sornchai Looareesuwan, Polrat Wilairatana Korean J Parasitol 2006;44(4):295-302. Published online December 20, 2006 DOI: https://doi.org/10.3347/kjp.2006.44.4.295 Abstract PDF Liver function tests were performed in 61 vivax, 54 malariae and 15 ovale malaria patients who were admitted to Bangkok Hospital for Tropical Diseases between 2001 and 2004. The objective of the study was to evaluate changes in hepatic biochemical indices before and after treatment with artemisinin derivatives. On admission and prior to treatment, hepatic dysfunction was found among the 3 groups. Serum liver function tests and physical examinations were performed weekly during the 28-day follow-up period. Initially elevated serum bilirubin and diminished albumin returned to normal within 2 weeks of treatment. Serum alkaline phosphatase and aminotransferases returned to within normal limits within 3 weeks. We conclude that patients with Plasmodium vivax, P. malariae and P. ovale infections had slightly elevated serum bilirubin, aminotransferase and alkaline phosphatase levels, and hypoalbuminemia. These minor abnormalities returned to normal within a few weeks after treatment with therapies based on artemisinin derivatives. Citations Citations to this article as recorded by The Dynamics of Liver Function Test Abnormalities after Malaria Infection: A Retrospective Observational Study John Woodford, G. Dennis Shanks, Paul Griffin, Stephan Chalon, James S. McCarthy The American Journal of Tropical Medicine and Hygiene.2018; 98(4): 1113. CrossRef Liver injury in uncomplicated malaria: an overlooked phenomenon Brioni R. Moore EBioMedicine.2018; 37: 15. CrossRef Quantitative Proteomics Analysis of Plasmodium vivax Induced Alterations in Human Serum during the Acute and Convalescent Phases of Infection Sandipan Ray, Sandip K. Patel, Apoorva Venkatesh, Gangadhar Chatterjee, Naziya N. Ansari, Nithya J. Gogtay, Urmila M. Thatte, Prajakta Gandhe, Santosh G. Varma, Swati Patankar, Sanjeeva Srivastava Scientific Reports.2017;[Epub] CrossRef Safety and Reproducibility of a Clinical Trial System Using Induced Blood Stage Plasmodium vivax Infection and Its Potential as a Model to Evaluate Malaria Transmission Paul Griffin, Cielo Pasay, Suzanne Elliott, Silvana Sekuloski, Maggy Sikulu, Leon Hugo, David Khoury, Deborah Cromer, Miles Davenport, Jetsumon Sattabongkot, Karen Ivinson, Christian Ockenhouse, James McCarthy, Photini Sinnis PLOS Neglected Tropical Diseases.2016; 10(12): e0005139. CrossRef Clinico-pathological studies of Plasmodium falciparum and Plasmodium vivax — malaria in India and Saudi Arabia Wajihullah Khan, Haytham Zakai, Umm-e-Asma Acta Parasitologica.2014;[Epub] CrossRef Association of Heme Oxygenase 1 with the Restoration of Liver Function after Damage in Murine Malaria by Plasmodium yoelii Sumanta Dey, Somnath Mazumder, Asim Azhar Siddiqui, M. Shameel Iqbal, Chinmoy Banerjee, Souvik Sarkar, Rudranil De, Manish Goyal, Samik Bindu, Uday Bandyopadhyay, J. H. Adams Infection and Immunity.2014; 82(8): 3113. CrossRef A STUDY OF CLINICAL PROFILE IN PATIENTS WITH P.VIVAX MALARIA Apte S., Jain J., Parmar A., Apte A., Sinha U, Chanchlani R Journal of Evolution of Medical and Dental Sciences.2014; 03(03): 575. CrossRef Mice lacking inducible nitric oxide synthase develop exacerbated hepatic inflammatory responses induced by Plasmodium berghei NK65 infection Onésia Cristina Oliveira-Lima, Danielle Bernardes, Mauro Cunha Xavier Pinto, Rosa Maria Esteves Arantes, Juliana Carvalho-Tavares Microbes and Infection.2013; 15(13): 903. CrossRef Clinico-laboratory profile of severe Plasmodium vivax malaria in a tertiary care centre in Kolkata Sayantan Ray, Manjari Saha, Debojyoti Sarkar, Arunansu Talukdar, Amitava Chakraborty Tropical Parasitology.2013; 3(1): 53. CrossRef Effect of artesunate based combination therapy with homeopathic medicine china on liver and kidney of Plasmodium berghei infected mice A. Rajan, U. Bagai, S. Chandel Journal of Parasitic Diseases.2012;[Epub] CrossRef A Case of Plasmodium ovale Malaria Imported from West Africa SeJin Moon, Baek-Nam Kim, Eun-Young Kuak, Tae Hee Han Laboratory Medicine Online.2012; 2(1): 51. CrossRef Retrospective analysis of vivax malaria patients presenting to tertiary referral centre of Uttarakhand Saurabh Srivastava, Sohaib Ahmad, Nadia Shirazi, Sanjiv Kumar Verma, Prashant Puri Acta Tropica.2011; 117(2): 82. CrossRef Ictericia y hepatopatía en el paciente con malaria Ana del Mar Cortina, Alberto Tobón Infectio.2010; 14(4): 277. CrossRef Clinical Features of Children Hospitalized with Malaria—A Study from Bikaner, Northwest India Dhanpat Kumar Kochar, Ashish Das, Shilpi Garg, Sanjay Kumar Kochar, Ghanshyam Singh Sengar, Gajanand Singh Tanwar, Anjana Gupta, Abhishek Kochar, Deepak Pakalapati, Vishal Saxena, Poonam Chand Khatri, Sheetal Middha, Jyoti Acharya The American Journal of Tropical Medicine and Hygiene.2010; 83(5): 981. CrossRef Chloroquine pharmacokinetics in pregnant and nonpregnant women with vivax malaria Sue Jean Lee, Rose McGready, Christine Fernandez, Kasia Stepniewska, Moo Koo Paw, Samuel Jacher Viladpai-nguen, Kyaw Lay Thwai, Leopoldo Villegas, Pratap Singhasivanon, Brian M. Greenwood, Nicholas J. White, François Nosten European Journal of Clinical Pharmacology.2008; 64(10): 987. CrossRef Bilirubin inhibits Plasmodium falciparum growth through the generation of reactive oxygen species Sanjay Kumar, Mithu Guha, Vinay Choubey, Pallab Maity, Kumkum Srivastava, Sunil K. Puri, Uday Bandyopadhyay Free Radical Biology and Medicine.2008; 44(4): 602. CrossRef 8,594 View 133 Download Crossref